When Simone Surgeoner returned to Melbourne after living in the United States for six years, she felt like her life had fallen apart.
I was in a really, really dark place and I just couldnt get myself out of it, the 49-year-old therapist said.
It felt like all the colours had been washed out of life I just had no motivation.
Ms Surgeoner had never taken any illicit drugs, but she was curious about whether taking tiny doses of psilocybin mushrooms otherwise known asmagic mushrooms could help her clear the fog.
So, she started taking 120 milligrams roughly 10 per cent of a standard recreational dose of the hallucinogena couple of times a week, an approach known as microdosing.
The dose was too small to trigger kaleidoscopic visuals or profound visions, but it was just enough to feel like the sun was shining again, Ms Surgeoner said.
It gave me back days where I just went, Oh, this is what it feels like to be happy and normal again,' she said.
"It gave me the strength to get through those dark periods."
Ms Surgeoner is among a growing number of people who aremicrodosing psychedelics, particularly psilocybin and LSD, to easeanxiety and depression, improvewellbeing, and boostcreativity and focus.
While no-one knows how many people microdose in Australia or overseas, online discussion groups suggestthe trend is picking up.
One Reddit microdosing community has grown to over 200,000 members since launching in 2013, and aFacebook group called "Psilocybin Microdosing 101" has gathered 14,000 members in two years.
Once the drugs of choice among hippies, music festival-goers and Silicon Valley workers, psychedelics have alsocaught the eye of researchers in recent years as potential treatments for mental health issues, including depression and anxiety.
In March last year, the federal government committed$15 million to supportclinical research that will investigate whether psychedelics can treat debilitating conditions likepost-traumatic stress disorder, depression, addiction, and eating disorders.
"Psychedelics have gone through this very interesting transition in the last few years from being something that is fairly taboo to something that people seem genuinely interested in, said Vince Polito, a cognitive psychologist at Macquarie University.
Despite this wave of interest, psychedelicsremain prohibited (Schedule 9)substancesin Australia. Last year, the Therapeutic GoodsAdministration (TGA) rejected a call to downscale psilocybin (and MDMA, or ecstasy)to controlled substances.
Get a selection of the best mental health content from across the ABC by subscribing to our monthly newsletter
While taking anLSD tab or taking a couple of grams of magic mushrooms triggers intense hallucinations and shifts in consciousness, taking a microdosetypically10 to 20 per cent of a standard or recreational dose often has a much subtler effect.
Jay (not their real name), a 25-year-old disability worker, said that for him, microdosing LSD is more likea "personal enhancer" than a full-blowntrip.
He said taking small doses of the drug hadhelped him overcome his social anxiety and become more confident.
"[Microdosing]helpsme connect with people on a social level, on an emotional level," said Jay, who is based in Sydney.
"Whereas [a full recreational dose] almost muddles up my internals a little bit I won't be able to talk, I won't be able to string my sentences together properly."
A handful of recent studies reveal people are drawn to microdosing for a variety of reasons.
A 2019 survey of more than 1.000 people found that the most common reasons totry microdosing are to enhance performance andimprove mood.
Another survey of over 400 microdosersrevealed that more than half took minuscule doses of psychedelics to help them cope with depression, anxiety, and ADHD.
The same study found that others microdose to find relief from physical ailments, including migraines, chronic pain, and cluster headaches.
Some people may turn to microdosing because they don't trust conventional treatmentslike antidepressant medications,or feel that they aren't effective, said Stephen Bright, a psychologist at Edith Cowan University.
"There is some bad public sentiment towards 'big pharma' and antidepressant drugs," Dr Bright said.
"People may have already tried an antidepressant drug and found that it wasn't particularly effective."
Another drawcard of microdosing is that it could be seen as more socially acceptable than taking a full-blown psychedelic trip, Dr Bright said.
"It almost feels like it's a way of trying to makepsychedelics fit within our current society."
Early results from trials on the therapeutic potential of large doses (macrodosing) of psychedelics have been promising.
So what about microdosing?Can tiny doses ofpsychedelics really lift depression, reduce anxiety and make you more creative and productive? The evidence we have so far is a mixed bag.
In May this year, Dr Polito co-authored a review of every single microdosing study that had been published between 1955 and 2021.
Dr Polito assessed the effects reported in the studies across various categories, from mood and mental health to creativityand cognition.
Several studies in the review suggested that microdosing psychedelics could indeed spark up your mood and reduce anxiety.
Another2019study on over 1,000 microdosers found that participants reported better moods, increased energy, and improved work performance.
And a 2021 studyonover 8,000participantsrevealed that among those with mental health concerns, microdosers said they experienced lower levels of depression, anxiety, and stress than their non-microdosing counterparts.
But while the results seem glowing on the surface, it's important to take them with a grain of salt, Dr Polito said.
"Most of the studies that have looked at mood and mental health show that people who microdose do report benefits and sometimes quite striking benefits," Dr Polito said.
"However, the majority of that research does come from self-report studies."
Unlike lab studies which are carried out in a controlled setting and often compare a drug's effects with a placebo self-report studies involve asking participants about their experiences through questionnaires, surveys or polls.
A benefit of this approachis that itoffers a cheap, straightforward way to collect data from a lot of people, particularly for research onillegal substances, whichare difficult to access due to regulatoryhurdles.
But these kinds of studiescome with their limitations, Dr Polito said.
"Typically, people that would be attracted to a study like that are people who are fans of microdosing so there's certainly a selection bias."
Dr Polito said another problem with self-report studies is there's no way of knowing for sure what, or how much, people are taking.
"[Self-report] studies rely on people's honesty in reporting what they've taken, how much they've taken. Even if someone is being very honest, they may not always know," Dr Polito said.
"Two people might say that they're taking half a gram of psilocybin mushrooms, but the actual psilocybin content of those mushrooms might be very, very different."
The controlled lab studies in Dr Polito's review of existing researchpainted a less promising picture.
Three studies found no noticeable changes in depression symptoms on the day participants took their dose, while fourfound that microdosing seemed to increase anxiety and stress levels.
"There is a fairly consistent minority of people who say that it doesn't make their mood improve it actually makes them more scatterbrained and emotional."
Other studies have shown there could be other forces at play.A 2021 placebo-controlled study onnearly 200 participants the largest study of its kind on psychedelics found participants did indeed noticea mental and emotional boost after takingmicrodoses of LSD for four weeks.
But those who received a placebo also noticed an improvement in their mental health, suggestingthat even the thought of taking a small dose of LSDwasas good as the real thing, a phenomenon known as the placebo effect.
"If people believe that it's going to reduce their anxiety, improve their depression, assist them in being more task-orientated and concentrate, they're likely to get that effect regardless of whether the drug gives them that effect," Dr Bright said.
"The placebo effect is extremely powerful."
So, does that hose down microdosing for good? Not necessarily, Dr Polito said.
He pointed out that it's important to remember that most lab studies have so far only assessed microdosing over a few weeks, whereas real-life microdosers often take psychedelics formonths.
"It may not be surprising that changes weren't found in those lab studies," Dr Polito said.
"If you gave someone three to six doses of a traditional antidepressant, you also wouldn't see much difference.
"It's only after someone has been taking those medications for six or 12 weeks that you see a difference."
Dr Bright agreesit's too early to tell if microdosing works or not, as most controlled studies have only been conducted on a small number of people.
"Before we can talk about whether [microdosing] is effective or not, there needs to be large clinical trials similar to those that we've already seen in the macrodosing space," Dr Bright said.
"Following on from that, if it does work we need to understand why it works."
Large, long-term studies would also reveal whether microdosing is safe enough to become the new therapeutic kid on the block.
Although microdosers may be less likely to have a bad trip, even a small dose of a hallucinogenic substance still has the potential to trigger psychotic episodes or other mental health issues, particularly for people with a history of bipolar disorder and schizophrenia.
Anotherconcern is that takingpsychedelicsregularly over long periods could lead to heart issues.
A handful of studies have shown that psychedelics, including psilocybin, LSD and MDMA, activate a receptor called5-HT2B, which plays a role in heart structure and function.
The activation of this receptor over long periods has been linked to valvular heart disease in high-dose MDMA users, but we don't knowwhether microdosing carries the same risk, Dr Polito said.
"That is a question that hasn't been answered yet.We really would need to do very long-term studies."
Dr Polito and his team arecurrently conducting a double-blind, placebo-controlled studythat will explore how microdosing psilocybin impacts the brain.
The researchers are aiming to recruit about 80 people to take part in two double-blind placebo-controlled lab sessions that will investigate whether reported effects, such as performance enhancement and improved mental health, can be confirmed in brain scans and blood biomarkers.
"We're really trying to get at this question of whether there is really a pharmacological effect, or whether this is mainly based on placebo expectations," Dr Polito said.
"If we find differences in neural activity between those two visits, that will be pretty good evidence that there are some physiological changes and that it's not just people's expectations."
Get the latest health news and information from across the ABC.
Continued here:
Can microdosing psychedelics improve your mental health? Here's what the science says - ABC News
- Review: Tripping on Utopia Complicates the History of Psychedelics - AOL - March 16th, 2024 [March 16th, 2024]
- Psychedelics Are Going Mainstream. Investing in Them Hasn't. - The Wall Street Journal - January 7th, 2024 [January 7th, 2024]
- Another Study Shows African Psychedelic Plant Ibogaine Treats Traumatic Brain Injury in Vets With 'Dramatic' Results - Good News Network - January 7th, 2024 [January 7th, 2024]
- Massachusetts Lawmakers Will Be Forced To Consider Psychedelics Legalization Measure That Activists Petitioned ... - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA to begin researching psychedelics as treatment option for veterans - Government Executive - January 5th, 2024 [January 5th, 2024]
- VA Is Funding New Research On Psychedelics' Benefits For Veterans With PTSD And Depression - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA ramps up study of psychedelic to treat PTSD - The American Legion - January 5th, 2024 [January 5th, 2024]
- Scientists predict DMT trip from cardiac activity - Big Think - January 5th, 2024 [January 5th, 2024]
- If psychedelics heal, how do they do it? | Proceedings of the National Academy of Sciences - pnas.org - January 5th, 2024 [January 5th, 2024]
- Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential | Molecular ... - Nature.com - January 5th, 2024 [January 5th, 2024]
- U.S. Rep. Correa supports using psychedelics to treat veterans with PTSD - New Santa Ana - January 5th, 2024 [January 5th, 2024]
- DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Psychedelics for Psych Conditions Made Their Mark in 2023 - Medpage Today - January 5th, 2024 [January 5th, 2024]
- 2023: A Good Trip Around the Sun for Psychedelics - The National Law Review - January 5th, 2024 [January 5th, 2024]
- Understanding the Role of the FDA in Advancing Psychedelic Therapy - Medriva - January 5th, 2024 [January 5th, 2024]
- MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics - Psychedelic Alpha - January 5th, 2024 [January 5th, 2024]
- Closing the innovation gap: Advancing psychedelic therapy and medicines in EU mental health care - Open Access Government - January 5th, 2024 [January 5th, 2024]
- The Austin Chronic: SXSW Is High on Psychedelics, as Cannabis Programming Wanes - Austin Chronicle - January 5th, 2024 [January 5th, 2024]
- This Forgotten Psychedelic Could Revolutionize Traumatic Brain Injury Treatment - Inverse - January 5th, 2024 [January 5th, 2024]
- A 'milestone' for psychedelics: Pentagon directed to study alternative treatments for veterans - Washington Times - January 5th, 2024 [January 5th, 2024]
- Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here's What's Next - Singularity Hub - January 5th, 2024 [January 5th, 2024]
- The top 8 psychedelic books you need to read | GreenState - GreenState - January 5th, 2024 [January 5th, 2024]
- Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC - Green Market Report - January 5th, 2024 [January 5th, 2024]
- DEA Calls For Even More THC, Psilocybin And DMT To Be Produced For Research In 2024 - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Here's What You Missed in Cannabis, Psychedelics This Week - TipRanks.com - TipRanks - January 5th, 2024 [January 5th, 2024]
- You're not tripping: State and local leaders give psychedelics another chance - Route Fifty - December 22nd, 2023 [December 22nd, 2023]
- Are Consciousness-Expanding Psychedelics Like Psilocybin More Effective Than Prozac, Zoloft, Xanax, and Other ... - Nautilus - December 22nd, 2023 [December 22nd, 2023]
- RFK, Ramaswamy And Williamson Push Psychedelics Reform On Presidential Campaign Trail - Marijuana Moment - December 22nd, 2023 [December 22nd, 2023]
- Peyote is the darling of the psychedelics renaissance. Indigenous users say it co-opts a sacred way of life - The Guardian US - December 22nd, 2023 [December 22nd, 2023]
- USask researchers explore untold history of psychedelics - News - University of Saskatchewan - USask News - December 22nd, 2023 [December 22nd, 2023]
- California Governor Says Psychedelics Have 'Profound' Healing Potential, But He's Undecided On Legalization Bill As ... - Marijuana Moment - September 25th, 2023 [September 25th, 2023]
- As psychedelic-assisted therapy grows, so does interest from a new group: chaplains - NPR - September 25th, 2023 [September 25th, 2023]
- This Maine City Moves Unanimously On Decriminalizing Psychedelics: Focus On Public Health - Benzinga - September 25th, 2023 [September 25th, 2023]
- Tech Leaders Are Finding Balance Through Microdosing Psychedelics - The Dales Report - September 25th, 2023 [September 25th, 2023]
- Chronic Pain Can Be Treated by Psychedelics, Survey Suggests - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Insights Into the First Psychedelic-Assisted Therapy Guidelines With ... - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Living with long-term cancer is depressing. Texas doctors say psychedelics could help - The Hill - July 19th, 2023 [July 19th, 2023]
- Couples Are Doing MDMA and Ketamine Therapy To Save Their Relationships - VICE - July 19th, 2023 [July 19th, 2023]
- The Way People Are Using Psychedelics Is Changing Amid Reform ... - Marijuana Moment - July 19th, 2023 [July 19th, 2023]
- [WATCH] Turn on, tune in, legalise: Could psychedelics be next in ... - MaltaToday - July 19th, 2023 [July 19th, 2023]
- Will Psychedelics Be Rescheduled After FDA Approval? - Harris Bricken - July 19th, 2023 [July 19th, 2023]
- The Psychedelic Preparedness Scale: A Tool to Optimize Trip ... - Filter - July 19th, 2023 [July 19th, 2023]
- How to Test Psychedelics for Adulterants with Testing Kits - Psychedelic Spotlight - July 19th, 2023 [July 19th, 2023]
- Cannabis Science Conference to debut in Providence, R.I., with ... - GlobeNewswire - July 19th, 2023 [July 19th, 2023]
- New Speaker Rivas weighs in on psychedelics, housing and health care worker minimum wage - Yahoo News - July 19th, 2023 [July 19th, 2023]
- TDR's Top 5 Psychedelic Developments For The Week Of July 10 - The Dales Report - July 19th, 2023 [July 19th, 2023]
- Psychedelic Treatment with Psilocybin Relieves Major Depression, Study ... - February 20th, 2023 [February 20th, 2023]
- Johns Hopkins Launches Center For Psychedelic Research - February 20th, 2023 [February 20th, 2023]
- Psilocybin Treatment for Major Depression Effective for Up to a Year ... - February 20th, 2023 [February 20th, 2023]
- Inside the Johns Hopkins Psilocybin Playlist - Hopkins Medicine - February 20th, 2023 [February 20th, 2023]
- Research Story Tip: Psychedelic Drug Psilocybin Tamps Down Brains Ego ... - February 20th, 2023 [February 20th, 2023]
- Psychedelics: Risks, benefits, and more - Medical News Today - February 18th, 2023 [February 18th, 2023]
- Psychedelic Drug Effects, Side Effects & Dangers - January 25th, 2023 [January 25th, 2023]
- Psychedelics Decriminalization Project In Berkeley, Cal Includes ... - January 6th, 2023 [January 6th, 2023]
- Ancient mummified child was drugged with psychedelics before ritual ... - December 14th, 2022 [December 14th, 2022]
- The therapeutic potential of psychedelics - Science - December 14th, 2022 [December 14th, 2022]
- Changing Lives with Psychedelics: How Connecticut researchers are using magic mushrooms to help people overcome depression, OCD - WTNH.com - November 19th, 2022 [November 19th, 2022]
- Penis Envy Mushroom | Legal Psychedelics | Magic Mushroom - November 7th, 2022 [November 7th, 2022]
- Psychedelics. Discussing natural and synthetic friends. Science, News ... - November 5th, 2022 [November 5th, 2022]
- The Harms of Psychedelics Need to Be Put Into Context - WIRED - November 5th, 2022 [November 5th, 2022]
- Packers' Aaron Rodgers says psychedelics led to his back-to-back MVP ... - October 28th, 2022 [October 28th, 2022]
- With Promise of Legalization, Psychedelic Companies Joust Over Future Profits - The New York Times - October 25th, 2022 [October 25th, 2022]
- How do psychedelics work? This brain region may explain their effects - PBS - October 21st, 2022 [October 21st, 2022]
- Why is the American right suddenly so interested in psychedelic drugs? - The Guardian - October 19th, 2022 [October 19th, 2022]
- Can Psychedelics Cure? Science Is on the Verge of Finding Out - Newsweek - October 19th, 2022 [October 19th, 2022]
- Large national survey suggests that the use of psychedelics is not associated with lifetime cancer development - PsyPost - October 19th, 2022 [October 19th, 2022]
- This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More - Small Pharma - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Made the Mushrooms Magic: Psychedelic Study Explores the Odd Evolution of Mind-Altering Fungi - The Debrief - October 19th, 2022 [October 19th, 2022]
- Psychedelics And Wellness: The Healing Company Buys PepsiCo-Backed Superfoods Company - (HLCO) - Benzinga - October 19th, 2022 [October 19th, 2022]
- What's on the Colorado ballot? Housing, psychedelics, school meals, alcohol, taxes and more | FOX31 Denver - FOX 31 Denver - October 19th, 2022 [October 19th, 2022]
- DoseConnect to Sponsor the Tech Stage at Wonderland Miami by Microdose - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Is Going on With Bright Minds (DRUG) Stock Today? - InvestorPlace - October 19th, 2022 [October 19th, 2022]
- Psychedelics May Ease Fear of Death and Dying - October 17th, 2022 [October 17th, 2022]
- TDR's Top 5 Psychedelic Developments For The Week Of October 10 - The Dales Report - October 17th, 2022 [October 17th, 2022]
- DEA Wants To Boost Production Of Cannabis & Psychedelics For Research In 2023 - Benzinga - October 17th, 2022 [October 17th, 2022]
- Talk set to explore psychedelics and mental health - Reading Today - October 17th, 2022 [October 17th, 2022]
- Silo Wellness Closes Acquisition of Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- How does psilocybin rewire the brain? - Open Access Government - October 17th, 2022 [October 17th, 2022]
- HYTN Awarded Controlled Drugs and Substances Dealers License Allowing for Production and Sale of Psilocybin - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- The Healing Company acquires leading superfoods business, Your Super, and lands $150M credit facility to expand community of brands - Yahoo Finance - October 17th, 2022 [October 17th, 2022]